Additionally, a study indicated that sulforaphane, known for its antioxidant properties and ability to reduce ROS, lowers IL-6 and NF-κB levels in a rat model of AD, suggesting that IL-6-induced ROS activation triggers the NF-κB and vice versa (64). This evidence concerns the gene IL6 and Alzheimer disease.